Nosocomial Infections
19
1
1
13
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 19 trials
100.0%
+13.5% vs benchmark
5%
1 trials in Phase 3/4
15%
2 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (19)
Evaluation of Rapid Diagnostic Device for the Detection of Candida Auris
Nosocomial Respiratory Virus Infection
Optimal Antibiotic Treatment of Moderate to Severe Bacterial Infections
Lipid Kinetics of Patients With Pneumonia
Effect of Metallic Nanoparticles on Nosocomial Bacteria
Reduction of Infection in Neonatal Intensive Care Units Using the Evidence-based Practice for Improving Quality
Study of Bathing With Chlorhexidine Impregnated Cloths on Nosocomial Infections in the Pediatric Intensive Care Unit
A Efficacy and Safety Study of Nasal Prongs With Proprietary Surface Coating Aiming to Reduce Bacterial Colonization
Multi-center Observational Study to Evaluate Epidemiology and Resistance Patterns of Common ICU-Infections (MOSER)
Efficacy of Copper in Reducing Health-Acquired Infections in a Pediatric Intensive Care Unit
ED Residents MBP During CVC Placement: Sim Lab Based Training
Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants
Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Bovine Lactoferrin as a Natural Regimen of Selective Decontamination of the Digestive Tract in Patients With Prolonged Mechanical Ventilation
Impact of Antibiotic Treatment on Outcome in Patients With Ventilator-Associated Tracheobronchitis
Simulation-based Training for Surgery Residents in Aseptic Techniques
Surveillance for Nosocomial Infections in Pediatric Cancer Patients
Potential Nosocomial Infection Prevention Via Modification of Anesthesia Intraoperative Aseptic Practice
Comparison of Two Protocols to Prevent the Acquisition of Methicillin-Resistant Staphylococcus Aureus.